Google just announced a smorgasbord of new AI tools for productivity and creativity at its Google I/O keynote on Tuesday, but not many of them are available for free right now.

By AJ Vicens May 20 (Reuters) - Early fears that Anthropic’s new AI model, Mythos, could dramatically turbocharge hacking are looking overstated a month after its release. The company warned at launch in April that Mythos had uncovered thousands of software vulnerabilities — including flaws across every major operating system and browser — and said the fallout from its spread could be severe.

Adobe released Photoshop version 27.7 today, and one of the most interesting additions is an on-device AI model for

OpenAI says one of its internal AI models has solved the planar unit distance problem, a famous maths puzzle first posed by Paul Erdős in 1946. The result challenges a decades-old belief about square-grid constructions and has been checked by external mathematicians.

By Kenrick Cai MOUNTAIN VIEW, California, May 19 (Reuters) - Alphabet CEO Sundar Pichai will kick off Google's annual developer conference on Tuesday where the tech giant is expected to reveal a flurry of artificial intelligence upgrades for consumers and coders.

Even if you aren’t using Google Gemini, it might be using your device. Security researcher Alexander Hanff, also known as “That Privacy Guy,” recently reported that Google’s widely used Chrome web browser is quietly storing an on-device AI model without explicitly asking for user permission.

The order, which is expected this week, comes as the Trump administration grapples with the national security implications of advanced cyber-focused AI models like Anthropic’s Mythos.

The White House could issue as soon as Thursday an executive order pushing for a voluntary government review of new artificial intelligence models before they’re released publicly, sources with knowledge of the situation told CNN.

May 20 (Reuters) - Bristol Myers Squibb said on Wednesday it is partnering with Anthropic to make its Claude AI model available to over 30,000 employees in an effort to accelerate the discovery, development and delivery of new medicines.